Skip to main content
Log in

Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin forCampylobacter jejuni diarrhea

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

In an AIDS patient with diarrhea, identical isolates ofCampylobacter jejuni susceptible and, later, resistant to macrolide antibiotics were isolated from feces before and after treatment with clarithromycin. Results of rRNA gene restriction analysis and serotyping suggest that development of resistance rather than simultaneous infection with a susceptible and a resistant strain was responsible for this phenomenon. This is the first report of in vivo development of resistance byCampylobacter jejuni in a patient treated with a macrolide forCampylobacter jejuni infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Riley LW, Finch MJ: Results of the first year of national surveillance ofCampylobacter infections in the United States. Journal of Infectious Diseases 1985, 151: 956–959.

    PubMed  Google Scholar 

  2. Blaser MJ:Campylobacter species. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 1649–1658.

    Google Scholar 

  3. Sorvillo FJ, Lieb LE, Waterman SH: Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. Journal of Acquired Immune Deficiency Syndromes 1991, 4: 598–602.

    PubMed  Google Scholar 

  4. Endtz HP, Broeren M, Mouton RP: In vitro susceptibility of quinolone-resistantCampylobacter jejuni to new macrolide antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 1993, 12: 48–50.

    Google Scholar 

  5. Goossens H, De Boeck M, Butzler JP: A new selective medium for the isolation ofCampylobacter jejuni from human faeces. European Journal of Clinical Microbiology 1983, 2: 389–393.

    PubMed  Google Scholar 

  6. Penner JL:Campylobacter, Helicobacter, and related spiral bacteria. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1991, p. 402–409.

    Google Scholar 

  7. National Committee for Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A2. NCCLS, Villanova, PA, 1990.

    Google Scholar 

  8. Funke G, Lüthy-Hottenstein J, Altwegg M: The E test for antimicrobial susceptibility testing of clinicalCampylobacter jejuni andCampylobacter coli isolates. Medical Microbiology Letters 1993, 2: 168–175.

    Google Scholar 

  9. Martinetti G, Altwegg M: rRNA gene restriction patterns and plasmid analysis as a tool for typingSalmonella enteritidis. Research in Microbiology 1990, 141: 1151–1162.

    PubMed  Google Scholar 

  10. Adler-Mosca H, Lüthy-Hottenstein J, Martinetti Lucchini G, Burnens A, Altwegg M: Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. European Journal of Clinical Microbiology and Infectious Diseases 1991, 10: 953–957.

    Google Scholar 

  11. Penner JL, Hennessy JN: Passive hemagglutination technique for serotypingCampylobacter fetus subsp.jejuni on the basis of soluble heat-stable antigens. Journal of Clinical Microbiology 1980, 12: 732–737.

    PubMed  Google Scholar 

  12. Taylor DE, Eaton M, Yan W, Chang N: Genome maps ofCampylobacter jejuni andCampylobacter coli. Journal of Bacteriology 1992, 174: 2332–2337.

    PubMed  Google Scholar 

  13. Yan W, Taylor DE: Characterization of erythromycin resistance inCampylobacter jejuni andCampylobacter coli. Antimicrobial Agents and Chemotherapy 1991, 35: 1989–1996.

    PubMed  Google Scholar 

  14. Taylor DE, Chang N: In vitro susceptibilities ofCampylobacter jejuni andCampylobacter coli to azithromycin and erythromycin. Antimicrobial Agents and Chemotherapy 1991, 36: 1917–1918.

    Google Scholar 

  15. Perlman DM, Ampel NM, Schifman RB, Cohn DL, Patton CM, Aguirre ML, Wang WL, Blaser MJ: PersistentCampylobacter jejuni infections in patients infected with human immunodeficiency virus (HIV). Annals of Internal Medicine 1988, 108: 540–546.

    PubMed  Google Scholar 

  16. Dworkin B, Wormser GP, Abdoo RA, Cabello F, Aguero ME, Sivak SL: Persistence of multiply antibiotic-resistantCampylobacter jejuni in a patient with the acquired immune deficiency syndrome. American Journal of Medicine 1986, 80: 965–970.

    PubMed  Google Scholar 

  17. Bernard E, Roger PM, Carles D, Bonaldi V, Fournier JP, Dellamonica P: Diarrhea andCampylobacter infections in patients infected with the human immunodeficiency virus. Journal of Infectious Diseases 1989, 159: 143–144.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Funke, G., Baumann, R., Penner, J.L. et al. Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin forCampylobacter jejuni diarrhea. Eur. J. Clin. Microbiol. Infect. Dis. 13, 612–615 (1994). https://doi.org/10.1007/BF01971317

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01971317

Keywords

Navigation